Cargando…

Advances in stem cell therapy for peritoneal fibrosis: from mechanisms to therapeutics

Peritoneal fibrosis (PF) is a pathophysiological condition caused by a variety of pathogenic factors. The most important features of PF are mesothelial–mesenchymal transition and accumulation of activated (myo-)fibroblasts, which hinder effective treatment; thus, it is critical to identify other pra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Weiyan, Xia, Demeng, Bi, Wendi, Lai, Xueli, Yu, Bing, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566108/ https://www.ncbi.nlm.nih.gov/pubmed/37817212 http://dx.doi.org/10.1186/s13287-023-03520-3

Ejemplares similares

Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
por: Lu, Xiaohui, et al.
Publicado: (2023)

Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022)

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
por: Terri, Michela, et al.
Publicado: (2021)

Advancements in adipose-derived stem cell therapy for skin fibrosis
por: Liu, Yu-Xin, et al.
Publicado: (2023)

Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
por: Strippoli, Raffaele, et al.
Publicado: (2016)

Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription
por: Zhao, Tingting, et al.
Publicado: (2023)

A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis
por: Li, Jin’e, et al.
Publicado: (2023)

Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity
por: Raby, Anne-Catherine, et al.
Publicado: (2018)

Autophagy in peritoneal fibrosis
por: Su, Hong-yong, et al.
Publicado: (2023)

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
por: Tan, Zui, et al.
Publicado: (2021)

Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
por: Li, Fang, et al.
Publicado: (2022)

Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
por: Fang, Cheng-Chung, et al.
Publicado: (2012)

Metabolomics study of fasudil on cisplatin-induced kidney injury
por: Xia, Demeng, et al.
Publicado: (2019)

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis
por: Wang, Jie, et al.
Publicado: (2013)

The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis
por: Stepanova, Natalia
Publicado: (2023)

Nano-sized carriers in gene therapy for peritoneal fibrosis in vivo
por: Igarashi, Yusuke, et al.
Publicado: (2017)

Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances
por: Yu, Zuxiang, et al.
Publicado: (2023)

Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis
por: Chen, Guobao, et al.
Publicado: (2019)

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
por: Wang, Wendi, et al.
Publicado: (2021)

Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal Metastases
por: Ghirardi, Valentina, et al.
Publicado: (2023)

The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis
por: Sung, Su Ah, et al.
Publicado: (2019)

Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis
por: Shen, Xianhe, et al.
Publicado: (2023)

Adipose-Derived Mesenchymal Stem Cells Modulate Fibrosis and Inflammation in the Peritoneal Fibrosis Model Developed in Uremic Rats
por: Costalonga, Elerson C., et al.
Publicado: (2020)

Kidney fibrosis: from mechanisms to therapeutic medicines
por: Huang, Rongshuang, et al.
Publicado: (2023)

Targeting cancer stem cells in squamous cell carcinoma
por: Chen, Demeng, et al.
Publicado: (2019)

An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles
por: Wang, Cui, et al.
Publicado: (2023)

Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis
por: Nagasaki, Kohei, et al.
Publicado: (2021)

Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis
por: Liu, An, et al.
Publicado: (2019)

Activation of AMPK-PGC-1α pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis
por: Wu, Jun, et al.
Publicado: (2022)

Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis
por: Liao, Chunling, et al.
Publicado: (2022)

Delayed bowel perforation after instilling over warmed peritoneal dialysate
por: Lai, Xueli, et al.
Publicado: (2021)

A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis
por: Lin, Fan, et al.
Publicado: (2015)

Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice
por: Zhu, Mengmei, et al.
Publicado: (2021)

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies
por: Feng, Lixiang, et al.
Publicado: (2023)

New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis
por: Witowski, Janusz, et al.
Publicado: (2015)

Editorial: Advances in Mechanisms of Renal Fibrosis
por: Lan, Hui Y., et al.
Publicado: (2018)

Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis
por: Luo, Qimei, et al.
Publicado: (2022)

The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
por: Zhang, Danyan, et al.
Publicado: (2022)

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis
por: Bu, Fang-tian, et al.
Publicado: (2022)

Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation
por: Liang, Jiabin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7m57k6lbqukp6k41eojhfm3lh0